Navigation Links
Accidental discovery produces durable new blue pigment for multiple applications
Date:11/16/2009

CORVALLIS, Ore. An accidental discovery in a laboratory at Oregon State University has apparently solved a quest that over thousands of years has absorbed the energies of ancient Egyptians, the Han dynasty in China, Mayan cultures and more the creation of a near-perfect blue pigment.

Through much of recorded human history, people around the world have sought inorganic compounds that could be used to paint things blue, often with limited success. Most had environmental or durability issues. Cobalt blue, developed in France in the early 1800s, can be carcinogenic. Prussian blue can release cyanide. Other blue pigments are not stable when exposed to heat or acidic conditions.

But chemists at OSU have discovered new compounds based on manganese that should address all of those concerns. They are safer to produce, much more durable, and should lead to more environmentally benign blue pigments than any being used now or in the past. They can survive at extraordinarily high temperatures and don't fade after a week in an acid bath.

The findings were just published in the Journal of the American Chemical Society, and a patent has been applied for on the composition of the compound and the process used to create it. The research was funded by the National Science Foundation.

"Basically, this was an accidental discovery," said Mas Subramanian, the Milton Harris Professor of Materials Science in the OSU Department of Chemistry. "We were exploring manganese oxides for some interesting electronic properties they have, something that can be both ferroelectric and ferromagnetic at the same time. Our work had nothing to do with looking for a pigment.

"Then one day a graduate student who is working in the project was taking samples out of a very hot furnace while I was walking by, and it was blue, a very beautiful blue," he said. "I realized immediately that something amazing had happened."

What had happened, the researchers said, was that at about 1,200 degrees centigrade almost 2,000 degrees Fahrenheit this otherwise innocuous manganese oxide turned into a vivid blue compound that could be used to make a pigment able to resist heat and acid, be environmentally benign and cheap to produce from a readily available mineral.

The newest and possibly the best blue pigment in world history was born, due to manganese ions being structured in an unusual "trigonal bipyramidal coordination" in the presence of extreme heat.

"Ever since the early Egyptians developed some of the first blue pigments, the pigment industry has been struggling to address problems with safety, toxicity and durability," Subramanian said.

The pigment may eventually find uses in everything from inkjet printers to automobiles, fine art or house paint, researchers say.

The scientists said in their journal article that the new compound yields "a surprisingly intense and bright blue color," and they have outlined its structure and characteristics in detail. Collaborating on the work were researchers in the Materials Department at the University of California/Santa Barbara.

"A lot of the most interesting discoveries are not really planned, we've seen that throughout history," Subramanian said. "There is luck involved, but I also teach my students that you have to stay alert to recognize something when it happens, even if it isn't what you were looking for."

"Luck favors the alert mind."


'/>"/>

Contact: Mas Subramanian
mas.subramanian@oregonstate.edu
541-737-8235
Oregon State University
Source:Eurekalert

Related biology news :

1. Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths
2. Discovery may help defang viruses
3. Stomach stem cell discovery could bring cancer insights
4. Symposium marks 30th anniversary of discovery of third domain of life
5. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
6. Natural product discovery by Cleveland medical researchers blocks tissue destruction
7. Researchers discovery may lead to hypertension treatment
8. Yale discovery suggests protein may play a role in severe asthma
9. Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration
10. Profound immune system discovery opens door to halting destruction of lupus
11. Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced ... will feature emerging and evolving technology through ... Innovation Summits will run alongside the expo portion of ... sessions, panels and demonstrations focused on trending topics within ... advanced design and manufacturing event will take place June ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: